| 1973 |
Biosafety Requirements in LPA Facility Design |
English |
Not specified |
|
Off |
| 1972 |
Biosafety Requirements in Line Probe Assay [LPA] Laboratory |
English |
Not specified |
|
Off |
| 1971 |
Incubation of MGIT Tubes |
English |
Not specified |
|
Off |
| 1970 |
Inoculation of MGIT Tubes |
English |
Not specified |
|
Off |
| 1969 |
Preparation of MGIT Tubes for MGIT TB Cultures |
English |
Not specified |
|
Off |
| 1968 |
Preparation of PANTA for MGIT TB Cultures |
English |
Not specified |
|
Off |
| 1967 |
Procedure for Culture Specimen Processing: CSF and other body fluids |
English |
Not specified |
|
Off |
| 1966 |
Procedure for Culture Specimen Processing: Urine |
English |
Not specified |
|
Off |
| 1965 |
Procedure for Culture Specimen Processing: Tissue |
English |
Not specified |
|
Off |
| 1964 |
Procedure for Culture Specimen Processing: Laryngeal Swab |
English |
Not specified |
|
Off |
| 1963 |
Procedure for Culture Specimen Processing: Bronchial Lavage |
English |
Not specified |
|
Off |
| 1962 |
Specimen Processing for TB Cultures |
English |
Not specified |
|
Off |
| 1961 |
BACTEC MGIT 960 PANTA |
English |
Not specified |
|
Off |
| 1960 |
BACTEC MGIT 960 Growth Supplement |
English |
Not specified |
|
Off |
| 1959 |
BACTEC MGIT 960 Tube with Media [7 ml] |
English |
Not specified |
|
Off |
| 1958 |
BACTEC MGIT 960 Reagents and Storage |
English |
Not specified |
|
Off |
| 1957 |
Monitoring Quality Indicators of Truenat |
English |
Not specified |
|
Off |
| 1956 |
Annual Maintenance of the Truenat Instrument |
English |
Not specified |
|
Off |
| 1955 |
Processing of Sputum Sample before Truenat Testing |
English |
Not specified |
|
Off |
| 1918 |
Overview of the Truenat Testing Process |
English |
Not specified |
|
Off |
| 1916 |
External Quality Assurance for CBNAAT |
English |
Not specified |
|
Off |
| 1914 |
CBNAAT Maintenance Record Keeping under NTEP |
English |
Not specified |
|
Off |
| 1912 |
CBNAAT Results Interpretation |
English |
Not specified |
|
Off |
| 1910 |
Adverse Event Definitions and Classifications |
English |
Not specified |
|
Off |
| 1908 |
Active TB Drug Safety Monitoring [aDSM] |
English |
Not specified |
|
Off |
| 1906 |
Management of DR-TB ADR: Dysglycaemia and Hyperglycemia |
English |
Not specified |
|
Off |
| 1905 |
Management of DR-TB ADR: Lactic Acidosis |
English |
Not specified |
|
Off |
| 1904 |
Management of DR-TB ADR: Superficial Fungal Infection and Thrush |
English |
Not specified |
|
Off |
| 1903 |
Management of DR-TB ADR: Alopecia |
English |
Not specified |
|
Off |
| 1902 |
Management of DR-TB ADR: Electrolyte Disturbances |
English |
Not specified |
|
Off |
| 1901 |
Management of DR-TB ADR: Optic Neuritis |
English |
Not specified |
|
Off |
| 1900 |
Management of DR-TB ADR: Vestibular Toxicity |
English |
Not specified |
|
Off |
| 1899 |
Management of DR-TB ADR: Peripheral Neuropathy |
English |
Not specified |
|
Off |
| 1898 |
Management of DR-TB ADR: Hepatitis |
English |
Not specified |
|
Off |
| 1897 |
Management of ADR: Rash, Allergy and Anaphylaxis Reaction |
English |
Not specified |
|
Off |
| 1896 |
Management of DR-TB ADR: QT Prolongation |
English |
Not specified |
|
Off |
| 1895 |
Details of Replacement Sequence of Drugs in Longer Oral M/XDR-TB Regimen |
English |
Not specified |
|
Off |
| 1894 |
Additional Considerations for the Use of Newer Drugs in Longer Oral M/XDR-TB Regimen |
English |
Not specified |
|
Off |
| 1893 |
Treatment Extension in Longer Oral M/XDR-TB Regimen |
English |
Not specified |
|
Off |
| 1892 |
Use of M/XDR-TB Regimen in Patients with Psychiatric Illness |
English |
Not specified |
|
Off |
| 1891 |
Use of M/XDR-TB Regimen in Patients with Seizure Disorders |
English |
Not specified |
|
Off |
| 1890 |
Role of Surgery in DR-TB Treatment |
English |
Not specified |
|
Off |
| 1889 |
DR-TB Treatment in Pregnancy: Recommendation for the Use of Contraception |
English |
Not specified |
|
Off |
| 1888 |
Principles for Management of MDR/RR-TB in Children |
English |
Not specified |
|
Off |
| 1887 |
Follow-up Evaluation of Patients on Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen |
English |
Not specified |
|
Off |
| 1886 |
Follow-up Monitoring of DR-TB Patients |
English |
Not specified |
|
Off |
| 1885 |
Key Considerations for the Use of Bedaquiline [Bdq] |
English |
Not specified |
|
Off |
| 1884 |
Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Drug Dose Administration |
English |
Not specified |
|
Off |
| 1883 |
Inclusion and Exclusion Criteria for the Use of Bedaquiline |
English |
Not specified |
|
Off |
| 1882 |
Access to New Regimens to Patients Seeking Care in Private/Other Sectors |
English |
Not specified |
|
Off |
